Diagnostic value of cerebrospinal fluid alpha-synuclein seed quantification in synucleinopathies
Ilaria Poggiolini(Istituto delle Scienze Neurologiche di Bologna), Laura Parkkinen(Nuffield Orthopaedic Centre), Anne Pavy‐Le Traon(Inserm), Claudia Trenkwalder(Universitätsmedizin Göttingen), Selene Seoyun Lee(University of Oxford), Ronald B. Postuma(Montreal Neurological Institute and Hospital), Yoav Ben‐Shlomo(University of Bristol), Jacques Montplaisir(Centre Intégré Universitaire de Santé et de Services Sociaux du Centre-Sud-de-l'Île-de-Montréal), Aadil El-Turabi(University of Oxford), Agustín Querejeta(University of Oxford), Elena Antelmi(University of Verona), Brit Mollenhauer(Paracelsus Elena Klinik Kassel), Giuseppe Plazzi(Istituto delle Scienze Neurologiche di Bologna), Friederike Sixel‐Döring(Philipps University of Marburg), Francesco Biscarini(University of Bologna), Wassilios G. Meissner(Centre National de la Recherche Scientifique), Jean‐François Gagnon(Université du Québec à Montréal), Michael Lawton(University of Bristol), Alexandra Foubert‐Samier(Centre National de la Recherche Scientifique), Vandana Ayyar Gupta(University of Oxford)
Cited by 190
Related Papers
MDS clinical diagnostic criteria for Parkinson's disease
|Movement Disorders|2015|7.4k
Diagnosis and management of dementia with Lewy bodies
|Neurology|2017|4.4k
Clinical diagnosis of progressive supranuclear palsy: The movement disorder society criteria
|Movement Disorders|2017|2.3k
The Parkinson Progression Marker Initiative (PPMI)
|Progress in Neurobiology|2011|1.9k
MDS research criteria for prodromal Parkinson's disease
|Movement Disorders|2015|1.3k